Physician-guided care in Florida and ColoradoFL (954) 953-3662  |  CO (720) 902-8247
Home / Guides / Intermittent Fasting vs Calorie Counting: What Randomized Trials Show

Intermittent Fasting vs Calorie Counting: What Randomized Trials Show

Randomized trials and reviews find intermittent fasting loses about the same weight as daily calorie cutting. Sample sizes, dropout, muscle and safety.

Before and after photo of a Healthy Weight Loss 4 U patient; individual results vary
Real Healthy Weight Loss 4 U patient photo. Individual results vary and are not guaranteed.

By the Healthy Weight Loss 4 U Clinical Content Team · Published October 19, 2026 · Updated October 19, 2026 · 10 min read

In short

In randomized trials, intermittent fasting usually produces about the same weight loss as cutting calories every day. In a 12-month trial of 139 adults with obesity, an 8-hour eating window plus calorie limits lost 8.0 kg versus 6.3 kg with calorie limits alone, a gap that was not statistically significant [1]. A 2026 Cochrane review of 22 trials and 1,995 adults found little to no difference in weight loss versus standard dietary advice [5].

Key takeaways

  • In the 139-person NEJM trial, 8-hour time-restricted eating added to calorie limits did not beat calorie limits alone: net difference -1.8 kg at 12 months (95% CI -4.0 to 0.4) [1].
  • In a 100-person, 1-year trial, alternate-day fasting lost 6.0% of body weight versus 5.3% for daily calorie restriction, and 38% of the fasting group dropped out versus 29% [2].
  • A 2025 BMJ network meta-analysis of 99 trials (6,582 adults) found alternate-day fasting beat daily calorie restriction by 1.29 kg, a gap below the authors' own 2 kg threshold for an important change [6].
  • The 2026 Cochrane review of 22 trials (1,995 adults) found little to no difference in weight loss between intermittent fasting and traditional dietary advice across 21 studies [5].
  • In the 12-week TREAT trial, time-restricted eating (noon to 8 p.m.) lost about 1.10 kg of lean mass in the in-person subset, and the authors urged caution about muscle [3].

What is the difference between intermittent fasting and calorie counting?

Calorie counting cuts intake by a similar amount every day, while intermittent fasting changes when you eat or how much you eat on certain hours or days. Researchers call the daily approach continuous energy restriction, and a 2025 BMJ review grouped fasting into alternate-day fasting, whole-day fasting and time-restricted eating [6].

The versions used in trials are specific. In the NEJM time-restricted eating trial, the fasting group ate only between 8:00 a.m. and 4:00 p.m. [1]. In the Chicago alternate-day trial, participants ate 25% of their energy needs on fast days and 125% on feast days [2]. In a 5:2 trial, participants ate normally five days a week and cut energy by 75% on two days [4]. The daily comparison diets were a steady cut of 25% (75% of needs) in the Chicago trial and about 20% in the 5:2 trial [2][4].

The research question is simple: does the fasting pattern add weight loss beyond the calories themselves? Most randomized trials say it adds little or nothing [1][4][5], which is what the rest of this article walks through. Randomized trials assign people by chance, so they are stronger evidence for cause and effect than surveys of people who chose to fast.

What did the time-restricted eating trials find?

The largest long trial found no meaningful extra benefit from an 8-hour eating window when calories were already restricted. Liu and colleagues randomized 139 adults with obesity for 12 months. Both groups got calorie targets of 1,500 to 1,800 kcal a day for men and 1,200 to 1,500 for women, and one group also ate only between 8:00 a.m. and 4:00 p.m. [1].

At 12 months, the time-restricted group had lost 8.0 kg (95% CI 6.4 to 9.6) and the calorie-only group 6.3 kg (95% CI 4.7 to 7.8). The net difference of 1.8 kg was not statistically significant (95% CI -4.0 to 0.4; P = 0.11). Waist circumference, BMI, body fat, lean mass and blood pressure followed the same pattern, and adverse events did not differ substantially. The confidence interval includes zero but also includes a benefit of up to 4.0 kg, so the trial cannot rule out a small effect in either direction [1].

The TREAT trial tested eating in a window without any calorie advice. Lowe and colleagues randomized adults with overweight or obesity (116 in the main analysis, BMI 27 to 43, 60% men) for 12 weeks to eat freely from noon to 8 p.m. or to keep three structured meals a day. The fasting group lost about 0.94 kg and the comparison group about 0.68 kg, and the difference between groups was not significant (P = 0.63) [3]. Self-reported adherence in the fasting group was 83.5% of logged days (1,128 of 1,351), and 105 of 141 randomized participants (74.5%) completed the protocol [3].

How did alternate-day fasting and 5:2 compare with daily calorie cuts?

In both trials, alternate-day and 5:2 fasting ended up close to daily calorie restriction after the first months. Trepanowski and colleagues randomized 100 adults with obesity (86 women, mean age 44, mean BMI 34) to alternate-day fasting, daily calorie restriction or no intervention for one year, with 6 months of weight loss followed by 6 months of maintenance [2].

At month 6, both diets lost 6.8% of body weight relative to controls. At month 12 the figures were 6.0% for alternate-day fasting (95% CI -8.5% to -3.6%) and 5.3% for daily restriction (95% CI -7.6% to -3.0%). Dropout was 13 of 34 (38%) in the alternate-day group, 10 of 35 (29%) in the daily group and 8 of 31 (26%) in controls. Alternate-day fasters ate more than prescribed on fast days and less than prescribed on feast days. LDL cholesterol was 11.5 mg/dL higher with alternate-day fasting at month 12. The authors concluded that it did not produce superior adherence, weight loss, maintenance or cardioprotection [2].

The 5:2 trial randomized 150 adults with overweight or obesity (BMI 25 to under 40, aged 35 to 65) to a 5:2 pattern, a continuous 20% deficit, or a control group, with a 12-week intervention and about 50 weeks in total. At 12 weeks, weight loss was 7.1% for 5:2, 5.2% for continuous restriction and 3.3% for controls (5:2 versus continuous, P = 0.053). At week 50 it was 5.2%, 4.9% and 1.7%, with no significant gap between the two diets (P = 0.89). The authors concluded that 5:2 may be equivalent but not superior [4].

Key randomized trials of fasting patterns versus daily calorie restriction or usual eating
TrialDesign and sizeResultDropout or completion
Liu, NEJM 2022 [1]139 adults with obesity; 8-hour eating window plus calorie limits vs calorie limits alone; 12 months-8.0 kg vs -6.3 kg; net -1.8 kg, P = 0.11118 of 139 (84.9%) completed
Trepanowski, JAMA Intern Med 2017 [2]100 adults with obesity; alternate-day fasting vs daily restriction vs control; 12 months-6.0% vs -5.3% of body weight at month 12Dropout 38% vs 29% vs 26%
Schübel, Am J Clin Nutr 2018 [4]150 adults with overweight or obesity; 5:2 vs continuous 20% deficit vs control; about 50 weeksWeek 50: -5.2% vs -4.9% vs -1.7%; P = 0.89 for 5:2 vs continuousNot reported in the abstract
Lowe, JAMA Intern Med 2020 (TREAT) [3]116 adults; eating noon to 8 p.m. vs three structured meals; 12 weeks, no calorie advice-0.94 kg vs -0.68 kg; difference P = 0.63105 of 141 randomized (74.5%) completed

What do the large reviews conclude?

The large reviews agree that intermittent fasting works about as well as other calorie-reduction approaches, but they disagree on details and the evidence is mostly short. A 2025 BMJ systematic review and network meta-analysis pooled 99 randomized trials with 6,582 adults (body weight was analyzed in 93 trials and 6,247 people) [6].

Compared with eating as usual, alternate-day fasting lowered weight by 3.40 kg (95% CI -4.14 to -2.67), whole-day fasting by 2.36 kg, continuous calorie restriction by 2.11 kg and time-restricted eating by 1.72 kg [6]. Against continuous restriction, only alternate-day fasting did better, by 1.29 kg (95% CI -1.99 to -0.59; moderate certainty). Time-restricted eating and whole-day fasting showed no significant difference from continuous restriction [6].

Average weight difference versus eating as usual, by strategy (BMJ 2025 network meta-analysis)

Source: [6] Semnani-Azad et al., BMJ 2025 [6]. Bars show kilograms lost relative to ad libitum eating.

The authors set a minimum important weight change of 2 kg, so the 1.29 kg edge of alternate-day fasting over daily restriction falls below it. Most trials were short (median 12 weeks, only 17 of 99 lasting 24 weeks or more). In those 17 longer trials, alternate-day fasting, time-restricted eating and continuous restriction did not differ from one another, and adherence was often poor in longer trials [6].

The Cochrane Database of Systematic Reviews published a review on February 16, 2026, with searches current to November 5, 2024. It included 22 randomized trials with 1,995 adults with overweight or obesity treated at home or in the community [5]. Compared with traditional dietary advice, fasting made little to no difference to weight loss (21 studies, 1,430 people). Compared with no treatment or a waiting list, it likely made little to no difference (6 studies, 427 people; moderate certainty). Confidence was low to very low for most other outcomes, and follow-up was up to 12 months [5].

The two reviews used different eligibility rules and comparisons: the BMJ analysis included healthy adults and adults with existing conditions, while Cochrane included only adults with overweight or obesity [5][6]. Their headline numbers should not be set side by side as if they measured the same thing.

How well do people stick with fasting, and what happens to muscle?

Dropout was similar to or higher than with daily calorie cuts in the trials above, and the lean-mass data are limited but worth noting. About 15% of Liu trial participants did not reach the 12-month visit, and 38% of the alternate-day group left the Chicago trial [1][2].

On side effects, a 2024 meta-analysis in Nutrition Journal pooled 15 randomized trials with 1,365 adults with overweight or obesity. It found no significant difference from controls in fatigue, headache or dropout, and a numerically higher but not statistically significant rate of dizziness in one time-restricted eating subgroup. The authors called for larger, longer trials [7]. The Cochrane summary lists fatigue, headache and feeling sick as examples of reported effects, rates were uncertain, and Cochrane notes that side effects were inconsistently reported across the small trials [5][12].

On muscle, the TREAT trial raised a flag. In its 50-person in-person subset, the time-restricted group lost about 1.10 kg of lean mass and 0.64 kg of appendicular (arm and leg) lean mass, and appendicular lean mass index fell significantly more than in the comparison group (P = 0.005). The authors urged caution and called for studies of protein intake and meal timing [3]. In the Liu trial, where participants also followed calorie limits, lean mass changes did not differ between groups [1]. Neither result proves that fasting costs muscle in everyone, and the lean-mass numbers come from small subsets or secondary outcomes.

Who should not fast without medical advice?

Several groups were screened out of at least one major trial, so its results do not apply to them. The TREAT trial excluded people who were pregnant, breastfeeding or planning pregnancy within 6 months, people with type 1 or type 2 diabetes, people taking glucose-lowering drugs, people with a history of anorexia or bulimia, people with cancer and people who had weight-loss surgery [3]. Being left out of a trial does not mean fasting is safe or unsafe for these groups, so those decisions belong with a clinician.

The medication risk is documented on drug labels. The LANTUS (insulin glargine) label, revised 5/2025, states that hypoglycemia is the most common adverse reaction with insulins and lists changes in meal pattern, such as macronutrient content or timing of meals, among factors that may raise hypoglycemia risk [9]. The AMARYL (glimepiride) label says all sulfonylureas can cause severe hypoglycemia and that it is more likely when caloric intake is deficient [10]. Anyone who takes insulin or a sulfonylurea should talk with the prescriber before changing meal timing or fasting, and should not change doses on their own.

There is also an observational warning that is not yet settled. In March 2024 the American Heart Association released a conference abstract using NHANES data from more than 20,000 US adults, followed for a median of 8 years. Eating within less than 8 hours a day was associated with a 91% higher risk of cardiovascular death compared with eating across 12 to 16 hours. The association came from self-reported diet recalls, the AHA labeled the finding preliminary until peer-reviewed, and it does not show that eating windows caused the deaths [8].

Does fasting add anything for people taking a GLP-1 medicine?

No randomized trial has tested fasting together with a GLP-1 medicine, so there is no direct evidence of added benefit or added safety. A 2025 narrative review in Biomedicines (a structured but not systematic search) states that no clinical trials have directly evaluated the safety of combining the two approaches and that its proposals should not be read as proof of synergy [11].

The review lists theoretical concerns rather than trial findings. It notes that a measurable absolute loss of lean tissue accompanies most drug-induced weight loss, that GLP-1 medicines can reduce protein and micronutrient intake, and that long fasting windows carry a risk of nutrient deficiency. It also says that nausea, early satiety and reflux could in theory be intensified by prolonged fasting windows [11]. Anyone already on a GLP-1 medicine who is considering fasting should raise it with the prescribing clinician first.

What this means in practice

  • Treat eating windows, alternate-day fasting and 5:2 as one possible way to lower total calories, not as a method that beats calorie reduction; trials found similar results at 12 months [1][2][4].
  • Pick the pattern you can keep, because dropout was 15% to 38% in the trials above and the longer trials showed no clear winner [1][2][6].
  • Ask whether protein and strength activity are part of the plan, since TREAT's drop in appendicular lean mass led the authors to call for studies of protein and meal timing [3].
  • Do not change meal timing on your own if you use insulin or a sulfonylurea; labels name meal pattern and low caloric intake as hypoglycemia factors [9][10].
  • If you are pregnant, breastfeeding, planning pregnancy or have ever had an eating disorder, skip fasting experiments until a clinician has weighed in; the TREAT trial excluded these groups [3].
  • If you take a GLP-1 medicine, remember that no trial has tested adding fasting to it, so ask the prescriber before restricting your eating window [11].
  • Expect the evidence to keep changing: most fasting trials are short, with a median length of 12 weeks in the BMJ review, and the Cochrane review's follow-up was up to 12 months [5][6].

When to talk to a clinician

Talk with a licensed clinician before you start fasting if you have diabetes or take any glucose-lowering medicine, are pregnant or trying to conceive, have a history of an eating disorder, take a GLP-1 medicine, or have a heart condition. A clinician can review your history, medicines and goals, and decide whether any eating pattern is appropriate for you. This article describes research and does not predict what any pattern would do for an individual.

At Healthy Weight Loss 4 U, every program begins with a clinician evaluation, and that evaluation is the place to raise intermittent fasting, calorie goals or any change in how you eat. Your clinician decides what, if anything, is right for you after that evaluation, and no outcome is promised.

Frequently asked questions

Is intermittent fasting better than counting calories for weight loss?
In most randomized trials it is about the same. In a 12-month trial of 139 adults, an 8-hour eating window plus calorie limits did not significantly beat calorie limits alone [1]. A 2026 Cochrane review of 22 trials found little to no difference in weight loss versus standard dietary advice [5]. Alternate-day fasting edged ahead by 1.29 kg in one 2025 meta-analysis, below the authors' 2 kg threshold [6].
Does eating in an 8-hour window work without counting calories?
The 12-week TREAT trial tested it with no calorie advice. Adults eating from noon to 8 p.m. lost about 0.94 kg versus 0.68 kg for a structured-meals group, and the difference was not significant [3]. The BMJ review found time-restricted eating lowered weight by 1.72 kg versus eating as usual, with no significant edge over continuous calorie restriction [6].
Is alternate-day fasting harder to stick with?
In the 1-year Chicago trial, 38% of the alternate-day group dropped out versus 29% on daily calorie restriction and 26% of controls. Participants also ate more than prescribed on fast days and less on feast days, while the daily group generally met its goals [2]. A single trial cannot settle adherence, and the BMJ review says adherence was often poor in longer trials [6].
Will intermittent fasting cost me muscle?
The evidence is limited. In the TREAT trial, the time-restricted group lost about 1.10 kg of lean mass in the 50-person in-person subset, and appendicular lean mass index fell more than in the comparison group [3]. The Liu trial, which included calorie limits, found no group difference in lean mass [1]. The authors of TREAT called for more work on protein intake and meal timing.
Is it safe to fast if I take insulin or a sulfonylurea?
Do not decide that on your own. The LANTUS label lists changes in meal pattern, including timing of meals, among factors that may increase hypoglycemia risk [9]. The AMARYL label says sulfonylureas can cause severe hypoglycemia and that it is more likely when caloric intake is deficient [10]. Talk with the prescriber before changing when you eat, and do not adjust doses yourself.
Can I combine fasting with a GLP-1 medicine?
No randomized trial has tested the combination. A 2025 narrative review states that no clinical trials have directly evaluated its safety and raises theoretical concerns about lean-mass loss, low protein and micronutrient intake, and intensified nausea or reflux [11]. If you take a GLP-1 medicine, ask the prescribing clinician before narrowing your eating window.
Who should avoid intermittent fasting?
The TREAT trial excluded pregnant, breastfeeding and soon-to-conceive adults, people with diabetes or on glucose-lowering drugs, and people with a history of anorexia or bulimia [3]. That means its results do not speak to those groups. A clinician should weigh in before anyone in these groups changes how they eat, and the call is individual.
Does the American Heart Association study mean fasting is dangerous?
Not on its own. The March 2024 abstract used NHANES data from more than 20,000 adults and linked eating within under 8 hours a day to a 91% higher risk of cardiovascular death versus 12 to 16 hours [8]. It relied on self-reported diet, was labeled preliminary until peer-reviewed, and shows association rather than cause [8].

Sources

  1. Calorie Restriction with or without Time-Restricted Eating in Weight Loss. New England Journal of Medicine (PubMed record), 2022. pubmed.ncbi.nlm.nih.gov/35443107/
  2. Effect of Alternate-Day Fasting on Weight Loss, Weight Maintenance, and Cardioprotection Among Metabolically Healthy Obese Adults: A Randomized Clinical Trial. JAMA Internal Medicine (PubMed record), 2017. pubmed.ncbi.nlm.nih.gov/28459931/
  3. Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial. JAMA Internal Medicine (PubMed Central), 2020. pmc.ncbi.nlm.nih.gov/articles/PMC7522780
  4. Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial. American Journal of Clinical Nutrition (PubMed record), 2018. pubmed.ncbi.nlm.nih.gov/30475957/
  5. Intermittent fasting compared with dietary advice or no treatment for adults with overweight or obesity (Cochrane review CD015610). Cochrane Database of Systematic Reviews, 2026. www.cochrane.org/evidence/CD015610_intermittent-fasting-traditional-dietary-advice-or-no-treatment-which-works-better-help-adults
  6. Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials. BMJ, 2025. www.bmj.com/content/389/bmj-2024-082007
  7. Adverse events profile associated with intermittent fasting in adults with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Nutrition Journal, 2024. nutritionj.biomedcentral.com/articles/10.1186/s12937-024-00975-9
  8. 8-hour time-restricted eating linked to a 91% higher risk of cardiovascular death. American Heart Association Newsroom, 2024. newsroom.heart.org/news/8-hour-time-restricted-eating-linked-to-a-91-higher-risk-of-cardiovascular-death
  9. LANTUS (insulin glargine) injection prescribing information, Section 5.3 Hypoglycemia. DailyMed, National Library of Medicine (sanofi-aventis U.S. LLC label, revised 5/2025), 2025. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5e07a0c-7e14-4756-9152-9fea485d654a
  10. AMARYL (glimepiride) tablets prescribing information, Section 5.1 Hypoglycemia. DailyMed, National Library of Medicine (sanofi-aventis U.S. LLC label, revised 6/2023), 2023. dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=222b630b-7e09-43b4-9894-3d87f10add91
  11. Added Value to GLP-1 Receptor Agonist: Intermittent Fasting and Lifestyle Modification to Improve Therapeutic Effects and Outcomes. Biomedicines (narrative review), 2025. www.mdpi.com/2227-9059/13/12/3079
  12. Evidence behind intermittent fasting for weight loss fails to match hype (Cochrane news, February 16, 2026). Cochrane, 2026. www.cochrane.org/about-us/news/evidence-behind-intermittent-fasting-weight-loss-fails-match-hype
General information, not medical advice. Results vary and treatment depends on evaluation by a licensed clinician. This article was prepared by the Healthy Weight Loss 4 U Clinical Content Team from the published sources listed above. Nothing here is a recommendation for a specific person, and no treatment is started without an evaluation by a licensed clinician.

Keep reading

Protect Muscle During Weight Loss: What the Evidence Shows

Read →

Metabolic Adaptation and Weight Loss Plateaus Explained

Read →

Protein, Meal Planning and Meal Replacements for Weight Loss

Read →

How GLP-1 Medications Work for Weight Loss

Read →

Exercise and Weight Loss: What the Evidence Says

Read →

Questions about your own situation? A clinician can review your history and goals. Related: Personalized Weight Loss Counseling.

Book in Lighthouse Point, FL Book in Highlands Ranch, CO